Clinical Trial Update: A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results of Tarceva (erlotinib) in elderly patients with advanced non-small cell lung cancer; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 4 | Status: COMPLETED | Results posted: 2015-07-27